chr12-47964286-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001143842.2(TMEM106C):āc.50A>Cā(p.Lys17Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001143842.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM106C | ENST00000429772.7 | c.50A>C | p.Lys17Thr | missense_variant | 2/8 | 2 | NM_001143842.2 | ENSP00000400471.2 | ||
TMEM106C | ENST00000552546.5 | c.50A>C | p.Lys17Thr | missense_variant | 2/7 | 4 | ENSP00000448268.1 | |||
TMEM106C | ENST00000548640.5 | c.50A>C | p.Lys17Thr | missense_variant | 2/7 | 3 | ENSP00000447254.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000717 AC: 18AN: 250990Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135640
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461750Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727148
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.50A>C (p.K17T) alteration is located in exon 2 (coding exon 1) of the TMEM106C gene. This alteration results from a A to C substitution at nucleotide position 50, causing the lysine (K) at amino acid position 17 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at